Daewoong Pharmaceutical Presents Baseline Characteristics Of 104 Patients In Global Phase 2 Trial For IPF Drug Candidate 'Bersiporocin' At ERS 2026

(MENAFN - PR Newswire) 104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion Study includes both antifibrotic-treated and untreated patients; ...